vs

Side-by-side financial comparison of IPG PHOTONICS CORP (IPGP) and Pennant Group, Inc. (PNTG). Click either name above to swap in a different company.

Pennant Group, Inc. is the larger business by last-quarter revenue ($289.3M vs $274.5M, roughly 1.1× IPG PHOTONICS CORP). IPG PHOTONICS CORP runs the higher net margin — 4.8% vs 3.0%, a 1.8% gap on every dollar of revenue. On growth, Pennant Group, Inc. posted the faster year-over-year revenue change (53.2% vs 17.1%). Pennant Group, Inc. produced more free cash flow last quarter ($17.4M vs $10.9M). Over the past eight quarters, Pennant Group, Inc.'s revenue compounded faster (35.8% CAGR vs 4.4%).

IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.

The Pennant Group, Inc. is a U.S.-headquartered healthcare services provider that delivers home health care, hospice services, senior living solutions, and skilled nursing support. It operates across dozens of U.S. states, serving primarily elderly and medically vulnerable populations through its network of localized care facilities.

IPGP vs PNTG — Head-to-Head

Bigger by revenue
PNTG
PNTG
1.1× larger
PNTG
$289.3M
$274.5M
IPGP
Growing faster (revenue YoY)
PNTG
PNTG
+36.0% gap
PNTG
53.2%
17.1%
IPGP
Higher net margin
IPGP
IPGP
1.8% more per $
IPGP
4.8%
3.0%
PNTG
More free cash flow
PNTG
PNTG
$6.5M more FCF
PNTG
$17.4M
$10.9M
IPGP
Faster 2-yr revenue CAGR
PNTG
PNTG
Annualised
PNTG
35.8%
4.4%
IPGP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IPGP
IPGP
PNTG
PNTG
Revenue
$274.5M
$289.3M
Net Profit
$13.3M
$8.6M
Gross Margin
36.1%
Operating Margin
1.2%
6.0%
Net Margin
4.8%
3.0%
Revenue YoY
17.1%
53.2%
Net Profit YoY
69.8%
50.0%
EPS (diluted)
$0.30
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IPGP
IPGP
PNTG
PNTG
Q4 25
$274.5M
$289.3M
Q3 25
$250.8M
$229.0M
Q2 25
$250.7M
$219.5M
Q1 25
$227.8M
$209.8M
Q4 24
$234.3M
$188.9M
Q3 24
$233.1M
$180.7M
Q2 24
$257.6M
$168.7M
Q1 24
$252.0M
$156.9M
Net Profit
IPGP
IPGP
PNTG
PNTG
Q4 25
$13.3M
$8.6M
Q3 25
$7.5M
$6.1M
Q2 25
$6.6M
$7.1M
Q1 25
$3.8M
$7.8M
Q4 24
$7.8M
$5.8M
Q3 24
$-233.6M
$6.2M
Q2 24
$20.2M
$5.7M
Q1 24
$24.1M
$4.9M
Gross Margin
IPGP
IPGP
PNTG
PNTG
Q4 25
36.1%
Q3 25
39.5%
Q2 25
37.3%
Q1 25
39.4%
Q4 24
38.6%
Q3 24
23.2%
Q2 24
37.3%
Q1 24
38.7%
Operating Margin
IPGP
IPGP
PNTG
PNTG
Q4 25
1.2%
6.0%
Q3 25
3.1%
4.5%
Q2 25
0.0%
5.3%
Q1 25
0.8%
6.0%
Q4 24
6.0%
4.9%
Q3 24
-108.7%
6.0%
Q2 24
4.7%
5.7%
Q1 24
7.6%
5.4%
Net Margin
IPGP
IPGP
PNTG
PNTG
Q4 25
4.8%
3.0%
Q3 25
3.0%
2.7%
Q2 25
2.6%
3.2%
Q1 25
1.6%
3.7%
Q4 24
3.3%
3.0%
Q3 24
-100.2%
3.4%
Q2 24
7.8%
3.4%
Q1 24
9.6%
3.1%
EPS (diluted)
IPGP
IPGP
PNTG
PNTG
Q4 25
$0.30
$0.25
Q3 25
$0.18
$0.17
Q2 25
$0.16
$0.20
Q1 25
$0.09
$0.22
Q4 24
$0.27
$0.16
Q3 24
$-5.33
$0.20
Q2 24
$0.45
$0.18
Q1 24
$0.52
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IPGP
IPGP
PNTG
PNTG
Cash + ST InvestmentsLiquidity on hand
$839.3M
Total DebtLower is stronger
$168.8M
Stockholders' EquityBook value
$2.1B
$374.3M
Total Assets
$2.4B
$968.2M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IPGP
IPGP
PNTG
PNTG
Q4 25
$839.3M
Q3 25
$870.4M
Q2 25
$899.6M
Q1 25
$926.9M
Q4 24
$930.2M
Q3 24
$1.0B
Q2 24
$1.1B
Q1 24
$1.1B
Total Debt
IPGP
IPGP
PNTG
PNTG
Q4 25
$168.8M
Q3 25
$26.0M
Q2 25
$37.0M
Q1 25
$52.5M
Q4 24
$0
Q3 24
$108.9M
Q2 24
$82.2M
Q1 24
$83.3M
Stockholders' Equity
IPGP
IPGP
PNTG
PNTG
Q4 25
$2.1B
$374.3M
Q3 25
$2.1B
$343.0M
Q2 25
$2.1B
$333.6M
Q1 25
$2.1B
$323.0M
Q4 24
$2.0B
$312.0M
Q3 24
$2.1B
$187.3M
Q2 24
$2.3B
$173.0M
Q1 24
$2.3B
$164.2M
Total Assets
IPGP
IPGP
PNTG
PNTG
Q4 25
$2.4B
$968.2M
Q3 25
$2.4B
$753.6M
Q2 25
$2.4B
$751.4M
Q1 25
$2.3B
$743.6M
Q4 24
$2.3B
$679.5M
Q3 24
$2.4B
$646.8M
Q2 24
$2.5B
$602.5M
Q1 24
$2.6B
$578.2M
Debt / Equity
IPGP
IPGP
PNTG
PNTG
Q4 25
0.45×
Q3 25
0.08×
Q2 25
0.11×
Q1 25
0.16×
Q4 24
0.00×
Q3 24
0.58×
Q2 24
0.48×
Q1 24
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IPGP
IPGP
PNTG
PNTG
Operating Cash FlowLast quarter
$28.8M
$21.0M
Free Cash FlowOCF − Capex
$10.9M
$17.4M
FCF MarginFCF / Revenue
4.0%
6.0%
Capex IntensityCapex / Revenue
6.5%
1.2%
Cash ConversionOCF / Net Profit
2.17×
2.43×
TTM Free Cash FlowTrailing 4 quarters
$-3.5M
$36.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IPGP
IPGP
PNTG
PNTG
Q4 25
$28.8M
$21.0M
Q3 25
$35.3M
$13.9M
Q2 25
$-2.2M
$34.6M
Q1 25
$13.4M
$-21.2M
Q4 24
$73.8M
$20.6M
Q3 24
$66.1M
$7.7M
Q2 24
$53.5M
$10.5M
Q1 24
$54.6M
$545.0K
Free Cash Flow
IPGP
IPGP
PNTG
PNTG
Q4 25
$10.9M
$17.4M
Q3 25
$14.6M
$10.5M
Q2 25
$-17.6M
$31.6M
Q1 25
$-11.4M
$-23.2M
Q4 24
$50.6M
$17.2M
Q3 24
$43.0M
$6.8M
Q2 24
$29.2M
$8.9M
Q1 24
$26.5M
$-2.6M
FCF Margin
IPGP
IPGP
PNTG
PNTG
Q4 25
4.0%
6.0%
Q3 25
5.8%
4.6%
Q2 25
-7.0%
14.4%
Q1 25
-5.0%
-11.1%
Q4 24
21.6%
9.1%
Q3 24
18.4%
3.8%
Q2 24
11.3%
5.3%
Q1 24
10.5%
-1.7%
Capex Intensity
IPGP
IPGP
PNTG
PNTG
Q4 25
6.5%
1.2%
Q3 25
8.3%
1.5%
Q2 25
6.1%
1.4%
Q1 25
10.9%
0.9%
Q4 24
9.9%
1.8%
Q3 24
9.9%
0.5%
Q2 24
9.4%
1.0%
Q1 24
11.1%
2.0%
Cash Conversion
IPGP
IPGP
PNTG
PNTG
Q4 25
2.17×
2.43×
Q3 25
4.73×
2.29×
Q2 25
-0.34×
4.89×
Q1 25
3.58×
-2.73×
Q4 24
9.44×
3.57×
Q3 24
1.24×
Q2 24
2.65×
1.84×
Q1 24
2.27×
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IPGP
IPGP

Materials Processing$232.8M85%
Laser And Non Laser Systems$38.8M14%
Transferred Over Time$5.3M2%

PNTG
PNTG

Home Health Subsegment$136.2M47%
Hospice Subsegment$97.1M34%
Private And Other$36.4M13%
Medicare And Medicaid$19.6M7%
Affiliated Entity$2.2M1%

Related Comparisons